SEGMENT REPORTING - Net Sales and Segment Profit (Details) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
| Segment Reporting Information [Line Items] | ||||
| Segment Net Sales: | $ 3,305,000 | $ 4,031,000 | $ 13,186,000 | $ 11,180,000 |
| Segment Profit (Loss): | 280,000 | 1,931,000 | 3,622,000 | 5,839,000 |
| Non-cash share-based compensation | (2,606,000) | (8,137,000) | ||
| Depreciation and amortization | (508,000) | (337,000) | (1,562,000) | (1,440,000) |
| Intangible asset impairment | (19,000,000) | 0 | (19,000,000) | 0 |
| Loss from operations | (26,191,000) | (9,684,000) | (46,282,000) | (27,055,000) |
| Loss (gain) on debt extinguishment | 0 | (3,375,000) | 2,263,000 | (3,375,000) |
| Gain on remeasurement of warrant liability | (196,000) | (9,065,000) | (2,009,000) | (5,390,000) |
| Gain on investment | 0 | 0 | (6,851,000) | 0 |
| Foreign exchange loss | 768,000 | 298,000 | 1,420,000 | 1,137,000 |
| Interest (income) expense and amortization of debt issuance cost | (51,000) | 485,000 | 2,719,000 | 2,383,000 |
| Other expense (income), net | 101,000 | 964,000 | 111,000 | (123,000) |
| (Loss) Income before income tax | (26,813,000) | 1,009,000 | (43,935,000) | (21,687,000) |
| Operating Segments | ||||
| Segment Reporting Information [Line Items] | ||||
| Segment Net Sales: | 3,305,000 | 4,031,000 | 13,186,000 | 11,180,000 |
| Segment Profit (Loss): | (4,300,000) | (3,840,000) | (16,312,000) | (9,062,000) |
| Operating Segments | Cannabinoid | ||||
| Segment Reporting Information [Line Items] | ||||
| Segment Net Sales: | 979,000 | 875,000 | 4,269,000 | 2,131,000 |
| Segment Profit (Loss): | (4,395,000) | (4,391,000) | (17,421,000) | (10,859,000) |
| Operating Segments | Non-Cannabinoid | ||||
| Segment Reporting Information [Line Items] | ||||
| Segment Net Sales: | 2,326,000 | 3,156,000 | 8,917,000 | 9,049,000 |
| Segment Profit (Loss): | 95,000 | 551,000 | 1,109,000 | 1,797,000 |
| Other | ||||
| Segment Reporting Information [Line Items] | ||||
| Unallocated corporate expenses | (1,425,000) | (2,243,000) | (6,802,000) | (8,416,000) |
| Non-cash share-based compensation | (958,000) | (3,264,000) | (2,606,000) | (8,137,000) |
| Depreciation and amortization | (508,000) | (337,000) | (1,562,000) | (1,440,000) |
| Intangible asset impairment | (19,000,000) | 0 | (19,000,000) | 0 |
| Loss from operations | $ (26,191,000) | $ (9,684,000) | $ (46,282,000) | $ (27,055,000) |
| X | ||||||||||
- Definition Unallocated Corporate Expenses No definition available.
|
| X | ||||||||||
- Definition Warrant Liability, Remeasurement, Loss (Gain) No definition available.
|
| X | ||||||||||
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net amount of nonoperating interest income (expense). No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|